BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
8.37
-0.08 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
8.39
0.30%
After-hours: Aug 15, 2025, 06:15 PM EDT
BioCryst Pharmaceuticals Fail-to-Deliver
Total FTD Shares
315
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-95.1%
Negative Trend
FTD Chart
As of Jul 14, 2025,
BioCryst Pharmaceuticals Inc. has
315
shares failed to deliver, representing 0.01%
of the average daily volume of
3,913,816.5
shares. Over the past year, the monthly average FTD is
7,719
shares, with the current level 96% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 8.96 | 315 | -93.66% |
Jun 26, 2025 | 9.66 | 4.97K | +1331.70% |
May 29, 2025 | 10.88 | 347 | -99.43% |
Apr 25, 2025 | 8.39 | 60.92K | +64.41% |
Mar 26, 2025 | 7.8 | 37.05K | +751.79% |
Jan 29, 2025 | 8.02 | 4.35K | +12.87% |
Dec 30, 2024 | 7.53 | 3.85K | +1846.46% |
Nov 21, 2024 | 7.49 | 198 | -36.74% |
Oct 24, 2024 | 8.18 | 313 | -98.73% |
Sep 30, 2024 | 7.6 | 24.6K | +106.57% |
Aug 20, 2024 | 7.82 | 11.91K | +54022.73% |
Jul 24, 2024 | 7.4 | 22 | -99.66% |
Jun 28, 2024 | 6.18 | 6.41K | +12.08% |
May 31, 2024 | 6.46 | 5.72K | +535.78% |
Apr 24, 2024 | 4.21 | 900 | +14900.00% |
Mar 25, 2024 | 4.91 | 6 | -98.32% |
Feb 29, 2024 | 5.63 | 358 | -99.36% |
Jan 08, 2024 | 7.65 | 55.81K | +5072.20% |
Dec 29, 2023 | 5.99 | 1.08K | +693.38% |
Nov 30, 2023 | 5.88 | 136 | -32.00% |
Oct 24, 2023 | 5.7 | 200 | +300.00% |
Sep 26, 2023 | 7.35 | 50 | -98.60% |
Aug 08, 2023 | 7.02 | 3.57K | -5.89% |
Jul 27, 2023 | 7.75 | 3.79K | -29.94% |
Jun 30, 2023 | 7.04 | 5.41K | -78.80% |
May 19, 2023 | 8.44 | 25.51K | +65312.82% |
Apr 05, 2023 | 8.53 | 39 | -99.51% |
Mar 31, 2023 | 8.34 | 7.92K | +276.92% |
Feb 24, 2023 | 9.1 | 2.1K | -85.76% |
Jan 30, 2023 | 10.34 | 14.75K | n/a |